The 3-year clinical and functional course of schizophrenia among individuals with and without diabetes at study entry
- PMID: 17607334
- PMCID: PMC1896295
- DOI: 10.4088/pcc.v09n0206
The 3-year clinical and functional course of schizophrenia among individuals with and without diabetes at study entry
Abstract
Objective: This prospective observational study compared the 3-year clinical and functional course of schizophrenia among individuals with and without diabetes at study entry.
Method: Data were drawn from a large, 3-year, multisite, prospective, naturalistic study of treatment for schizophrenia-related disorders. The study was conducted in the United States between July 1997 and September 2003 and represented treatment practices in diverse systems of care. Participants were diagnosed with schizophrenia or schizoaffective or schizophreniform disorders based on DSM-IV criteria. Clinical and functional outcomes were assessed at study enrollment and at 12-month intervals using standard psychiatric measures, medical records, and a validated patient-reported questionnaire. Diabetes status was determined by participant interview at enrollment. Statistical analyses used mixed models with repeated measures.
Results: Of 594 participants queried about comorbid medical conditions at enrollment, 76 (12.8%) reported having diabetes. Other comor-bid conditions were reported by 79% of the diabetes group (N = 60) and 50% of the nondiabetes group (N = 259). Across the 3-year study, participants with diabetes differed significantly from participants without diabetes on 2 of 36 outcome measures: more contacts with nonpsychiatrist physicians (p < .001) and poorer physical health (p = .015). Groups did not differ significantly on mental health symptomatology, mental health resource utilization, legal and safety issues, substance use, productivity, activities and relationships, or quality of life.
Conclusions: In this 3-year, prospective, naturalistic study, the course of schizophrenia did not differ significantly between participants with and without diabetes, although persons with diabetes did have poorer physical health and more contacts with nonpsychiatrist physicians. Findings highlight the need for better medical treatment for people with schizophrenia, both with and without comorbid diabetes.
References
-
- Daumit GL, Pratt LA, and Crum RM. et al. Characteristics of primary care visits for individuals with severe mental illness in a national sample. Gen Hosp Psychiatry. 2002 24:391–395. - PubMed
-
- Sokal J, Messias E, and Dickerson FB. et al. Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. J Nerv Ment Dis. 2004 192:421–427. - PubMed
-
- Mukherjee S, Decina P, and Bocola V. et al. Diabetes mellitus in schizophrenic patients. Compr Psychiatry. 1996 37:68–73. - PubMed
-
- Ryan M, Collins P, Thakore JH.. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry. 2003;160:284–289. - PubMed
-
- Chafetz L, White MC, and Collins-Bride G. et al. The poor general health of the severely mentally ill: impact of schizophrenic diagnosis. Community Ment Health J. 2005 41:169–184. - PubMed
LinkOut - more resources
Full Text Sources